Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9596 posts found.

800px-nhs_nnuh_entrance_2

Thousands of coronavirus cases recorded in hospital were caught on site, new research suggests

August 26, 2020 Research and Development coronavirus

Thousands of coronavirus cases are thought to have been transmitted within UK hospitals, according to a new study. Researchers at …
News
unnamed_1

US Department of Justice charges Teva with generic price fixing

August 26, 2020 Research and Development Department of Justice, Teva Pharmaceuticals

The US Department of Justice (DOJ) has charged Teva Pharmaceuticals with conspiracy to fix the price of its generic drugs. …
News

75-year-old Nottinghamshire woman may be first known British victim of coronavirus

August 26, 2020 Research and Development COVID-19, coronavirus

A 75-year-old woman from Nottinghamshire is thought to be the first British case and victim of COVID-19. She tested positive …
News
8330379372_1e55f3c4c2_b

Africa declared free of wild polio

August 26, 2020 Research and Development polio, vaccines

The Africa Regional Certification Commission has declared Africa to be free from wild polio. Nigeria, Pakistan and Afghanistan were the …
News
fifififif

Working Life Interview: Fiona Huzarski, Vice President of Global HR, ADVANZ PHARMA

August 26, 2020 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Interview, Working Life, feature

“Every company is different, so you have to be open-minded and receptive to the culture when joining.” Can you briefly …
Feature
coroanrvisu_cdc

Pharmafile.com’s weekly COVID-19 news round-up

August 26, 2020 Research and Development COVID, COVID-19, coronavirus

In COVID-19 news this week, China is set to move ahead with human testing of a potential coronavirus vaccine that …
News
gilead-sciences

FDA turns down Gilead’s JAK inhibitor filgotinib in rheumatoid arthritis, endangering 2020 approval hopes

August 20, 2020 Research and Development, Sales and Marketing FDA, Gilead, filgotinib

Gilead’s JAK inhibitor filgotinib has been unexpectedly knocked back by the FDA as a therapy to treat moderately to severely …
News
fda_21

FDA delays BioMarin’s gene therapy for haemophilia A

August 20, 2020 Research and Development, Sales and Marketing FDA

The FDA has delayed Roctavin, BioMarin’s gene therapy for haemophilia A, by a year to wait for more extensive results, …
News
merckincweb2

MSD unveils plans for $1.3bn central London research centre

August 19, 2020 Manufacturing and Production, Research and Development London, MSD, pharma

MSD has lifted the lid on plans to build a $1.3 billion research centre in central London.The London Discovery Research …
News
sydney

Australia signs first COVID-19 vaccine deal for 25 million doses of AstraZeneca/Oxford University candidate

August 19, 2020 Research and Development AstraZeneca, Australia, COVID-19, pharma

Australia has signed its first deal to secure doses of a potential COVID-19 vaccine for its citizens, inking a partnership …
News
800px-temazepam_10mg_tablets-1

US states seek $26.4 billion from major pharmaceutical manufacturers and distributors to settle opioid litigation

August 19, 2020 Research and Development opioid crisis, opioid epidemic, opioids

Multiple Attorney Generals from across the US are seeking billions of dollars in damages to settle opioid cases against major …
News
bojo

UK Government officially announces National Institute for Health Protection to replace Public Health England

August 19, 2020 Research and Development opioid, opioid crisis, opioid epidemic

The UK Government has officially announced that Public Health England will be replaced by the National Institute for Health Protection. …
News
top_10_image_2

Pharmafile.com’s weekly COVID-19 news round-up

August 19, 2020 Research and Development coronavirus, top 10

Potentially unsafe coronavirus treatments are in the headlines this week, as President Donald Trump reportedly wants to approve Phoenix Biotechnology’s …
News
fda

Poseida suspends CAR T therapy trial in prostate cancer due to patient death

August 18, 2020 Manufacturing and Production, Research and Development CAR T, CAR-T, Poseida, patient death, pharma

Poseida’s Phase 1 trial that used an investigational CAR T therapy for treating prostate cancer has been suspended due to …
News
trummmuuuue

Trump allegedly “enthusiastic” for oleandrin to be approved as a COVID-19 treatment

August 18, 2020 Manufacturing and Production, Research and Development coronavirus vaccine, covid19

President Donald Trump reportedly wants to approve Phoenix Biotechnology’s oleandrin as a coronavirus treatment, despite a lack of evidence for …
News
The Gateway to Local Adoption Series

Latest content

Rhythm AI’s STAR Apollo system receives FDA clearance for atrial fibrillation

February 12, 2026

iOrganBio appoints Karol Jarzabek as Chief Operating Officer

February 12, 2026

Ensera Design expands UK leadership team with new senior appointments

February 11, 2026

Infinitopes announces $15.4m in additional seed funding to advance cancer vaccine

February 11, 2026

Angelini Pharma appoints Roberto Scrivo as Chief of External Affairs, Communication and Sustainability Officer

February 10, 2026